The study involved 40 patients with chemical burns of the stomach grade III-IV who had underwent standard therapy. The study involved 40 patients with chemical burns of the stomach grade III-IV who had underwent standard therapy.The complex therapy for 20 patients included 5 days of intravenous Rabeloc, 20 The complex therapy for 20 patients included 5 days of intravenous Rabeloc, 20mg daily. mg daily.
ResultsResults
Rabeloc included into the complex of therapeutic measures in patients with chemical burns of the stomach grade III–IV helped reduce the length of stay in the ICU by 1.5 times and inpatient treatment by 1.8 times, reduce the frequency of early secondary hemorrhage and decompensated cicatricial narrowing of the stomach. Rabeloc included into the complex of therapeutic measures in patients with chemical burns of the stomach grade III-IV helped reduce the length of stay in the ICU by 1.5 times and inpatient treatment by 1.8 times, reduce the frequency of early secondary hemorrhage and decompensated cicatricial narrowing of the stomach.